Wikidata

(Q39890184)

English

Mapatumumab and lexatumumab induce apoptosis in TRAIL-R1 and TRAIL-R2 antibody-resistant NSCLC cell lines when treated in combination with bortezomib

scientific article

In more languages

Statements

title
Mapatumumab and lexatumumab induce apoptosis in TRAIL-R1 and TRAIL-R2 antibody-resistant NSCLC cell lines when treated in combination with bortezomib (English)
1 reference
stated in
Europe PubMed Central
PubMed ID
19174554
retrieved
15 September 2017
author name string
Troy A Luster
series ordinal
1
1 reference
stated in
Europe PubMed Central
PubMed ID
19174554
retrieved
15 September 2017
Jeffrey A Carrell
series ordinal
2
1 reference
stated in
Europe PubMed Central
PubMed ID
19174554
retrieved
15 September 2017
Kathy McCormick
series ordinal
3
1 reference
stated in
Europe PubMed Central
PubMed ID
19174554
retrieved
15 September 2017
David Sun
series ordinal
4
1 reference
stated in
Europe PubMed Central
PubMed ID
19174554
retrieved
15 September 2017
Robin Humphreys
series ordinal
5
1 reference
stated in
Europe PubMed Central
PubMed ID
19174554
retrieved
15 September 2017
publication date
27 January 2009
1 reference
stated in
Europe PubMed Central
PubMed ID
19174554
retrieved
15 September 2017
page(s)
292-302
1 reference
stated in
Europe PubMed Central
PubMed ID
19174554
retrieved
15 September 2017

Identifiers

 
edit
    edit
      edit
        edit
          edit
            edit
              edit
                edit
                  edit
                    Retrieved from "https://www.wikidata.org/w/index.php?title=Q39890184&oldid=2092167665"